NRx Pharmaceuticals
NRXP
NRx Pharmaceuticals (NRXP) earnings history
Most recent quarter
- Fiscal period
- Q4 2025
- Period end
- Dec 31, 2025
- EPS actual
- $0.01
- EPS estimate
- −$0.07
- EPS surprise
- +114.29%
- Revenue surprise
- −72.83%
- Revenue
- $991,500.00
- Revenue estimate
- $3.6M
- Reported
- Mar 23, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q4 2025 | Mar 23, 2026 | −$0.07 | $0.01 | +114.29% | $991,500.00 | SEC |
| Q3 2025 | Nov 14, 2025 | −$0.13 | −$0.27 | −105.79% | $242,000.00 | SEC |
| Q2 2025 | Aug 18, 2025 | −$0.15 | −$0.98 | −552.46% | $0.00 | SEC |
| Q1 2025 | May 15, 2025 | −$0.28 | −$0.34 | −20.01% | $2.3M | SEC |
| Q4 2024 | Mar 14, 2025 | −$0.37 | −$0.72 | −97.52% | $0.00 | SEC |
| Q3 2024 | Nov 14, 2024 | −$0.56 | −$0.15 | +72.97% | $0.00 | SEC |
| Q2 2024 | Aug 14, 2024 | −$0.70 | −$0.75 | −7.91% | $0.00 | SEC |
| Q1 2024 | May 14, 2024 | −$0.55 | −$0.74 | −34.55% | $0.00 | SEC |
| Q4 2023 | Mar 29, 2024 | −$0.70 | −$0.50 | +28.57% | $0.00 | SEC |
| Q3 2023 | Nov 14, 2023 | −$1.10 | −$0.70 | +36.36% | $0.00 | SEC |
| Q2 2023 | Aug 14, 2023 | −$1.33 | −$1.20 | +10.00% | $0.00 | SEC |
| Q1 2023 | May 15, 2023 | −$1.35 | −$1.60 | −18.52% | $0.00 | SEC |
| Q4 2022 | Mar 31, 2023 | −$1.45 | −$1.50 | −3.45% | $0.00 | SEC |
| Q3 2022 | Nov 14, 2022 | −$1.40 | −$1.40 | +0.00% | $0.00 | — |
| Q2 2022 | Aug 15, 2022 | −$1.00 | −$1.10 | −10.00% | $0.00 | — |
| Q1 2022 | May 16, 2022 | $0.00 | −$2.10 | +0.00% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did NRx Pharmaceuticals (NRXP) last report earnings?
NRx Pharmaceuticals last reported on Mar 23, 2026, covering fiscal Q4 2025.
Did NRXP beat earnings estimates?
Yes. NRx Pharmaceuticals reported EPS of $0.01 for Q4 2025 against a −$0.07 estimate — a 114.29% beat.
How much revenue did NRXP report last quarter?
NRx Pharmaceuticals reported $991,500.00 in revenue for Q4 2025, against a consensus estimate of $3.6M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
